Vivek Charu

5.4k total citations · 1 hit paper
75 papers, 2.1k citations indexed

About

Vivek Charu is a scholar working on Epidemiology, Nephrology and Molecular Biology. According to data from OpenAlex, Vivek Charu has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Nephrology and 11 papers in Molecular Biology. Recurrent topics in Vivek Charu's work include Renal Diseases and Glomerulopathies (17 papers), Influenza Virus Research Studies (10 papers) and COVID-19 epidemiological studies (8 papers). Vivek Charu is often cited by papers focused on Renal Diseases and Glomerulopathies (17 papers), Influenza Virus Research Studies (10 papers) and COVID-19 epidemiological studies (8 papers). Vivek Charu collaborates with scholars based in United States, United Kingdom and Ireland. Vivek Charu's co-authors include Cécile Viboud, Lone Simonsen, A. Danielle Iuliano, Peter Spreeuwenberg, Robert J. Taylor, Joseph Bresee, John Paget, Marc Lipsitch, Edward Goldstein and Mark A. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Vivek Charu

66 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project

2019 439 citations Vivek Charu, Lone Simonsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vivek Charu United States	20	1.1k	517	352	226	207	75	2.1k
Magali Lemaître France	14	1.5k 1.3×	531 1.0×	498 1.4×	168 0.7×	126 0.6×	19	2.3k
Wenzhan Jing China	24	639 0.6×	530 1.0×	536 1.5×	143 0.6×	71 0.3×	53	2.2k
Mazen Hassanain Saudi Arabia	24	436 0.4×	164 0.3×	377 1.1×	233 1.0×	476 2.3×	98	2.1k
Ci Song China	17	414 0.4×	282 0.5×	810 2.3×	122 0.5×	290 1.4×	62	1.9k
Hsiu J. Ho Taiwan	22	1.3k 1.1×	150 0.3×	233 0.7×	240 1.1×	248 1.2×	55	2.8k
Paolo Sacchi Italy	24	808 0.7×	120 0.2×	828 2.4×	249 1.1×	148 0.7×	115	2.2k
Chad J. Achenbach United States	28	707 0.6×	144 0.3×	964 2.7×	55 0.2×	617 3.0×	124	2.5k
Patricia R. Blank Switzerland	21	856 0.7×	179 0.3×	170 0.5×	48 0.2×	98 0.5×	50	1.4k
Jayachandran Radhakrishnan United Kingdom	10	542 0.5×	200 0.4×	242 0.7×	129 0.6×	82 0.4×	11	1.5k
Lesley S. Park United States	19	600 0.5×	67 0.1×	642 1.8×	121 0.5×	543 2.6×	36	1.7k

Countries citing papers authored by Vivek Charu

Since Specialization

Citations

This map shows the geographic impact of Vivek Charu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Charu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Charu more than expected).

Fields of papers citing papers by Vivek Charu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Charu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Charu. The network helps show where Vivek Charu may publish in the future.

Co-authorship network of co-authors of Vivek Charu

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Charu. A scholar is included among the top collaborators of Vivek Charu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Charu. Vivek Charu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puga, Marco Antonio Moreira, Roberto Dias de Oliveira, Patrícia Vieira da Silva, et al.. (2025). Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil. The Lancet Regional Health - Americas. 44. 101031–101031.

Kim, W. Ray, Ajitha Mannalithara, Vivek Charu, et al.. (2025). Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease. The American Journal of Gastroenterology. 120(10). 2312–2320. 1 indexed citations

Puga, Marco Antonio Moreira, Roberto Dias de Oliveira, Patrícia Vieira da Silva, et al.. (2025). Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil. BMJ Public Health. 3(2). e002331–e002331.

Pan, Tao, Lü Tian, Manjula Kurella Tamura, Maria E. Montez‐Rath, & Vivek Charu. (2025). Discovering heterogeneous treatment effects on slope-based endpoints in chronic kidney disease trials. BMC Medical Research Methodology. 25(1). 230–230.

Pellegrini, Fabio, Menglan Pang, Carl de Moor, et al.. (2025). Bootstrapping the cross-validation estimate. The Annals of Applied Statistics. 19(4). 1 indexed citations

Wang, Aihui, Vivek Charu, Babak Litkouhi, et al.. (2024). Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients. Clinical Cancer Research. 30(13). 2801–2811. 1 indexed citations

Charu, Vivek, et al.. (2024). Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD. Hepatology. 80(5). 1184–1195. 12 indexed citations

Montez‐Rath, Maria E., I‐Chun Thomas, Vivek Charu, et al.. (2024). Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure. Annals of Internal Medicine. 177(9). 1233–1243. 8 indexed citations

McHenry, Austin, Kelly A. Devereaux, Stephanie Chow, et al.. (2024). Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours. Histopathology. 85(4). 614–626. 1 indexed citations

10.

Mehta, Neil, Scott W. Biggins, Sumeet K. Asrani, et al.. (2024). Model of Urgency for Liver Transplantation in Hepatocellular Carcinoma: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waitlist. Gastroenterology. 168(4). 784–794.e4. 1 indexed citations

11.

Dahlen, Alex & Vivek Charu. (2023). Analysis of Sampling Bias in Large Health Care Claims Databases. JAMA Network Open. 6(1). e2249804–e2249804. 23 indexed citations

12.

Charu, Vivek, Glenn M. Chertow, June Li, et al.. (2023). Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. Journal of the American Society of Nephrology. 35(2). 216–228. 3 indexed citations

13.

Cui, Lu, Zhuoqing Fang, Tristan Lerbs, et al.. (2023). Innate immune cell activation causes lung fibrosis in a humanized model of long COVID. Proceedings of the National Academy of Sciences. 120(10). e2217199120–e2217199120. 29 indexed citations

14.

Lafayette, Richard & Vivek Charu. (2023). Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies. Advances in Therapy. 40(12). 5557–5566. 1 indexed citations

15.

Sripongpun, Pimsiri, W. Ray Kim, Ajitha Mannalithara, et al.. (2022). The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care. Hepatology. 77(1). 256–267. 58 indexed citations

16.

Charu, Vivek, et al.. (2022). NELL1-Positive HIV-Associated Lupus-Like Membranous Nephropathy with Spontaneous Remission. SHILAP Revista de lepidopterología. 2(4). 184–188. 5 indexed citations

17.

Devereaux, Kelly A., Jennifer Pors, David F. Steiner, et al.. (2021). Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience. Modern Pathology. 35(5). 688–696. 37 indexed citations

18.

Charu, Vivek, Paul A. Rosenberg, Lon S. Schneider, et al.. (2017). Characterizing Highly Benefited Patients in Randomized Clinical Trials. The International Journal of Biostatistics. 13(1). 4 indexed citations

19.

Charu, Vivek, Lone Simonsen, Roger Lustig, Claudia Steiner, & Cécile Viboud. (2013). Mortality burden of the 2009‐10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza and Other Respiratory Viruses. 7(5). 863–871. 31 indexed citations

20.

Goldstein, Edward, Cécile Viboud, Vivek Charu, & Marc Lipsitch. (2012). Improving the Estimation of Influenza-Related Mortality Over a Seasonal Baseline. Epidemiology. 23(6). 829–838. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact